New pain combo cuts opioid need after bariatric surgery
NCT ID NCT07380503
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding a drug called dexmedetomidine to a standard numbing medicine (bupivacaine) could improve pain control after weight loss surgery in severely obese patients. 78 adults having laparoscopic bariatric surgery received an ultrasound-guided nerve block with either bupivacaine alone or bupivacaine plus different doses of dexmedetomidine. The main goal was to see if the combination reduced the need for opioid painkillers in the first day after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESPB WITH DEXMETOMIDINE MAY PROVIDE ANALGESIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ahmed Abdalla Mohamed
Cairo, 11451, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple drug cut bleeding risk in weight-loss surgery?
- Blood test clues could flag Weight-Surgery risks
- Can a higher dose of misoprostol help women with severe obesity avoid C-Section?
- Fasting test may unlock personalized obesity treatment
- Painkiller form may matter after gastric bypass
- Poop pills from skinny donors: a new weapon against obesity?